This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Layson-Wolf: The very first thing we need to do as pharmacists is to understand the concern that our patients have and to share information with them if they're willing, and we really have to work together as health care providers and we can hopefully answer our patients questions well.
Laura Knockel, PharmD, BCACP, clinical associate professor at Iowa College of Pharmacy, emphasized the critical importance of relying on professional organizations and trusted health care providers for accurate vaccine information, stressing the rigorous safety testing of vaccines and the potential risks of misinformation.
To address cost, pharmacists can recommend affordable options or biosimilars, check eligibility for manufacturer savings cards or patient assistance programs, like Lilly Insulin Value Program or Novo Nordisk Patient Assistance, and explore 340B pricing or over-the-counter insulins at reduced costs. Subscribe Now!
Health care practitioners (HCPs), and patients too, are sounding the alarm on unnecessary barriers in the system that can negatively impact patients’ access to quality care according to a new survey of HCPs and patients.
They will have insurance coverage, and that has helped tremendously to be able to adjust insulin doses. READ MORE: Insulin Management Resource Center Ready to impress your pharmacy colleagues with the latest drug information, industry trends, and patientcare tips? Sign up today for our free Drug Topics newsletter.
From prior authorizations to insurance roadblocks, each decision a pharmacy makes can either ease or complicate that experience. Whether it's trying to check out at a crowded store or navigating complex prescription issues, barriers frustrate people—and pharmacies are no different.
ACIP's recommendations are increasingly significant for pharmacies, influencing vaccination planning, billing, and patientcare activities. Community pharmacies, as trusted vaccination providers, must stay informed about ACIP proceedings and public discussions to address emerging patient inquiries effectively.
Despite a high prevalence of childhood and youth-aged obesity, the use of medications for treating obesity is persistently low among children and young adults (YA), according to an abstract presented at the American Diabetes Association’s 85th Scientific Sessions, held in Chicago, Illinois, from June 20-23, 2025. Accessed June 25, 2025.
After yet another record year for health data breaches, updated federal security rules to protect patient information are on the table in 2025. Increased privacy protections, in their view, would impact the financial viability of medical practices — especially small ones — and even timely patientcare.
They look at the list and they prioritize who they want to take on and who they don't want to take on based on their insurance plan and their drugs. Bottom line is, if the Rite Aid patients represent business that loses money, why would you want to take on those Rite Aid patients? That is a real problem.
Investigators find that current practices among pharmacists are not fully in alignment with American Diabetes Association (ADA) guideline recommendations for glucagon use, with frequently identified barriers including cost, patient health literacy, and insurance coverage. of patients on a short-acting insulin and 2.3%
Drug Topics: How do ACIP recommendations affect broader aspects of vaccine access and utilization, such as insurance reimbursement or public health programs? We utilize the ACIP guidelines as what we recommend for patients for preventive care to prevent diseases and things like that, [and] what's the best thing.
With rising drug costs, evolving health care regulations, and challenging reimbursement models, pharmacies must adopt strategic approaches to maintain financial health and continue providing patientcare.
Mifepristone Reduces HbA1c in Patients With T2D, Hypercortisolism | ADA 2025 / Carl - stock.adobe.com Data from CATALYST ( NCT05772169 ) showed that mifepristone met its primary endpoint of reduction in HbA1c compared to placebo at 24 weeks. Accessed June 26, 2025. June 23, 2025. Accessed June 26, 2025.
June 6, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The funds will support clinical milestones along with AI-driven development across Juvenescence’s portfolio. The acquisition forms a key part of Juvenescence’s partnership with the Abu Dhabi global healthcare company M42, which was announced in April 2025.
Steatosis liver disease (SLD) is associated with an increased risk of new-onset diabetes for patients with atrial fibrillation, especially for younger adults, according to results of a study published in Cardiovascular Diabetology. 1 Investigators included a total of 195,195 patients with AD, who had a mean age of 64.4 years and 57.5%
Intelligent medication management systems using RWD help hospitals forecast demand, respond to crises, and minimize medication expiration and loss, ultimately improving patientcare and operational efficiency. Jeff Webber Key Takeaways Real-world data enhances medication safety and supply chain efficiency.
Glucagon-like peptide-1 (GLP-1) receptor agonist use rose significantly among pediatric patients with type 2 diabetes from 2019 to 2024, according to recent data presented at the American Diabetes Association’s 85th Scientific Sessions, which were held June 20-23 in Chicago, Illinois. References 1.
Aside from disparities in HbA1c and overall CGM use, researchers uncovered inequities in CGM wear time and access, according to an abstract presented at the American Diabetes Association’s 85th Scientific Sessions, held in Chicago, Illinois, from June 20-23, 2025. Among those with T1D, at least 40% are using CGMs.
Robert Barrie July 16, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The BioIndustry Association (BIA) welcomed the plan, while the Association of the British Pharmaceutical Industry (ABPI) identified shortcomings. . Give your business an edge with our leading industry insights. Login Registration is disabled.
Ross Law July 3, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The UK Government’s plan focuses on digital transformation in the NHS, introducing new community centres for care, and adopting a more preventative approach to care. .” Give your business an edge with our leading industry insights.
Robert Barrie June 6, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook US health secretary Robert F Kennedy Jr. It will take a regulatory framework that makes sure that the [therapies] that do advance for patientcare are the ones that are actually safe and have excellent evidence behind them,” he added.
Abigail Beaney July 3, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The recent Westminster Health Forum included UK health specialists who discussed the benefit, risk and complications of creating a single, patient data system. Jefferson added: “Every project must deliver a tangible benefit to patients.
By 2025, healthcare data is projected to grow at an annual rate of 36% - outpacing industries like manufacturing, financial services, and media by as much as 11%. Informed decision-making requires evidence grounded in scientifically validated methodologies, whether for clinical development, regulatory approval, or patientcare.
In addition, ACIP recommendations usually trigger the first dollar coverage of vaccines by private insurers. 2,3 The next scheduled meeting for ACIP is June 25 to June 27, 2025. READ MORE: Immunization Resource Center Ready to impress your pharmacy colleagues with the latest drug information, industry trends, and patientcare tips?
Obesity-related mortality continued to rise following the COVID-19 pandemic, despite rates expected to stabilize during this time, according to an abstract presented at the American Diabetes Association’s 85th Scientific Sessions, held in Chicago, Illinois, from June 20-23, 2025. Accessed June 24, 2025. With at least 2.8 References 1.
Although 5G is currently limited to large cities in developed countries, by around 2025, we can expect its reach will extend beyond the urban areas. Let’s explore how this technology impacts insurance companies, healthcare providers (HCPs), pharma content , and pharmaceutical brands. HCPs The pandemic exposed many flaws in healthcare.
James Kirby, PharmD, BCPS, FAPhA, is PQAs Board Chair for 2025. No matter my role, I have always kept the patient at the center, trying to improve access to care and the quality of care they deserve. This means knowing patients deeply and collaborating with other members of their health team.
The pharmacists went beyond traditional medical interactions by educating patients about the importance of these health measures and helping them understand their personal health risks, according to Ramsbacher. Ready to impress your pharmacy colleagues with the latest drug information, industry trends, and patientcare tips?
A Senate investigation found that UHGs Medicare Advantage post-acute care denial rates skyrocketed from 10.9% And those numbers dont even touch private plans, where insurers are notorious for keeping denial data hidden. Their revenue projections for 2025 sit at an eye-watering $450 billion. in 2020 to 22% in 2022. Thats double.
According to the Deloitte report , the volume of health data rose by 40% between 2010 and 2020 and is predicted to climb even higher by 23% by 2025. This data is often duplicated and collected by hundreds of different HCPs, pharmaceutical companies, insurance bodies, public health agencies, and others.
Digital health is transforming the health care landscape through new technologies and platforms in patientcare management, conducting of clinical trials, patient data collection, and the diagnosis and treatment of disease. Global Strategy on Digital Health 2020-2025.” Ryan Hoshi. James Wabby. 1 November 2022.
The US imports a substantial volume of APIs and finished medicines, many of which are essential for patientcare, meaning these tariffs could have far-reaching implications. However, in the long term, increased costs could be passed on to healthcare systems, insurers, and ultimately, patients. Available from: [link] 2.
This blog recognizes 7 organizations that have joined PQA in 2025: Alnylam Pharmaceuticals Anticoagulation Forum Fairview Pharmacy Solutions Hematology/Oncology Pharmacy Organization MDI Health Milliman, Inc. New organizations regularly join PQA throughout the year. Samford University McWhorter School of Pharmacy See ourfull list of members.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content